VIDEO - BioAgilytix in 30 seconds - Bioanalytical Lab & Top CRO for Large Molecule Bioanalysis

VIDEO – BioAgilytix in 30 seconds

BioAgilytix is a leading bioanalytical contract research organization (CRO) that supports the development of novel therapeutic biologics and biosimilars. Located in Research Triangle Park, North Carolina, BioAgilytix specializes in large-molecule bioanalysis providing critical insight into the safety, efficacy, and mechanism of action of drug candidates throughout the clinical trial process. Specifically, BioAgilytix offers assay development, validation, and sample analysis services for immunoassays and cell-based assays under non-GLP, spirit-of-GLP, and GLP, as well as product release testing under GMP. BioAgilytix is an engaged and energetic partner committed to delivering exceptional value and veteran expertise through a collaborative process that consistently results in successful projects.

Cell-Based Assays

Learn how BioAgilytix provides the specialized large molecule insight and proven GLP / GMP knowledge needed to support a full range of cell-based assay (CBA) requirements.

Pharmacokinetics & Pharmacodynamics (PK/PD)

See how our PK expertise complements our immunogenicity services by evaluating absorption, distribution, metabolism and excretion characteristics of a product.

Case Studies

Learn why we’re a trusted partner to 22 of the top 25 global pharma and biotech companies.

Tell Us About Your Project

What are your specific assay needs? Let’s schedule a conversation to review your
questions and requirements with one of our scientists.

SPEAK TO A SCIENTIST

Featured Expert

Todd Lester, Associate Director

Steven Michael, Ph.D., Senior Vice President and Chief Operating Officer

Steven Michael, Ph.D.

Nathan Rudemiller, Ph.D., Associate Director

Nathan Rudemiller, Ph.D.

Michelle Miller, Ph.D. DABT, Associate Director

Michelle Miller, Ph.D. DABT

Marianne Scheel Fjording, Ph.D., Scientific Officer

Marianne Scheel Fjording, Ph.D.

Luke Armstrong, Ph.D., Manager II

Luke Armstrong, Ph.D.

Linda Robbie, Ph.D., Vice President and General Manager, Boston Operations

Linda Robbie, Ph.D.

Laura Lassen, Director

Krystal Alligood, Associate Director

Krystal Alligood

Kathryn Lindley, Vice President, Operations

Kathryn Lindley

Jim McNally, Ph.D., Chief Scientific Officer

Jim McNally, Ph.D.

Jessica Weaver, Manager II & Bioanalytical Project Manager

Jennifer Zemo, Ph.D., Director

Jennifer Zemo, Ph.D.

Jennifer Johnson, Manager I

Jennifer Johnson

Jennifer T. Durham, Ph.D., Associate Director of Scientific Services, BioAgilytix

Jennifer T. Durham, Ph.D.

Jeff Patrick, Ph.D., Director of GMP Operations, BioAgilytix

Jeff Patrick, Ph.D.

Janina Hajek, Ph.D., Principal Investigator

Janina Hajek, Ph.D.

Janett Schwarz, Ph.D., Principal Investigator

Janett Schwarz, Ph.D.

Imke Müller, Ph.D., Director, Principal Investigator

Imke Müller, Ph.D.

Frank Wischnewski, Ph.D., Associate Director

Frank Wischnewski, Ph.D.

Frank Horling, Ph.D., General Manager, Europe

Frank Horling, Ph.D.

Florian Anlauff, Ph.D., Principal Investigator

Florian Anlauff, Ph.D.

David Rusnak, Director, Bioanalytical Operations

Dave Williams, Ph.D., Vice President, Bioanalytical Operations

Dave Williams, Ph.D.

Daniel Worms, Ph.D., Associate Principal Investigator

Daniel Worms, Ph.D.

Chad Briscoe, Ph.D., Vice President, Business Development Europe

Chad Briscoe, Ph.D.

Carla Mejia, Manager II

Carla Gibbons, Senior QA Director

Anne Timmerman, Ph.D., Associate Principal Investigator

Anne Timmerman, Ph.D.

Anita Simkins, Senior Vice President, Global Quality Assurance

Amanda Hays, Ph.D., Scientific Officer

Amanda Hays, Ph.D.

Afshin Safavi, Ph.D., Founder & Board Member

Afshin Safavi, Ph.D.

Cell-Based Assays

Learn how BioAgilytix provides the specialized large molecule insight and proven GLP / GMP knowledge needed to support a full range of cell-based assay (CBA) requirements.

Pharmacokinetics & Pharmacodynamics (PK/PD)

See how our PK expertise complements our immunogenicity services by evaluating absorption, distribution, metabolism and excretion characteristics of a product.

Case Studies

Learn why we’re a trusted partner to 22 of the top 25 global pharma and biotech companies.

Tell Us About Your Project

What are your specific assay needs? Let’s schedule a conversation to review your
questions and requirements with one of our scientists.

SPEAK TO A SCIENTIST

Platforms

Services

USA HQ

2300 Englert Drive

Durham, NC 27713

919-381-6097

Fax 919-381-6099

Boston Laboratory

1320 Soldiers Field Road

Boston, MA 02135

617-456-0700

Fax 617-456-0701

San Diego Laboratory

9050 Camino Santa Fe

San Diego, CA 92121

858-652-4600

Fax 858-652-4699

European HQ

Lademannbogen 10

22339 Hamburg, Germany

+49 40 526779 0

Brisbane Laboratory

37 Kent St, Woolloongabba

Queensland, 4102, Australia

Melbourne Laboratory

85 Commercial Road, Melbourne

Victoria, 3004, Australia

Subscribe to Our Newsletter